PATENT CLAIM ANALYSIS

Application Number: 15903547
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "012000"]

Abstract:
The present invention provides methods for preventing and/or treating bleeding episodes by administering a single dose of a Factor VIIa equivalent. Preferably, the single dose comprises between about 150 and about 500 ug/kg Factor VIIa equivalent.

Claim (Index 5):
A method as defined in  claim 1 , wherein said Factor VIIa equivalent exhibits at least about 30% of the coagulant activity of Factor VIIa on a molar basis.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 88.0
- Lexical Diversity: 1.25806
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12127917', '10290814', '13987492', '15258908', '10255032']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7831169724735463
- 35 USC 102 Novelty (BERT): 0.6010964802170166
- Combined Prediction Score: 0.7649149232478933
- Mean Citation Score: 463.86342
- Max Citation Score: 646.3531
- Similarity Product: 429.3274977930785

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test